|
1
|
Genetically distinct subsets within ANCA-associated vasculitis.
|
N Engl J Med
|
2012
|
6.93
|
|
2
|
Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study.
|
Rheumatology (Oxford)
|
2011
|
1.74
|
|
3
|
New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes.
|
Hum Genet
|
2004
|
1.29
|
|
4
|
PGC-1alpha as modifier of onset age in Huntington disease.
|
Mol Neurodegener
|
2009
|
1.22
|
|
5
|
Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease.
|
J Mol Med (Berl)
|
2010
|
1.13
|
|
6
|
NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.
|
Hum Genet
|
2007
|
1.13
|
|
7
|
The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.
|
Neurogenetics
|
2005
|
1.06
|
|
8
|
ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.
|
J Mol Med (Berl)
|
2008
|
1.01
|
|
9
|
Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease.
|
Hum Genet
|
2006
|
1.00
|
|
10
|
Huntington's disease as caused by 34 CAG repeats.
|
Mov Disord
|
2008
|
0.99
|
|
11
|
Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
|
J Comp Neurol
|
2007
|
0.96
|
|
12
|
Venous thromboembolism in Wegener's granulomatosis.
|
J Rheumatol
|
2007
|
0.95
|
|
13
|
The low-penetrance R92Q mutation of the tumour necrosis factor superfamily 1A gene is neither a major risk factor for Wegener's granulomatosis nor multiple sclerosis.
|
Ann Rheum Dis
|
2007
|
0.94
|
|
14
|
Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of beta2-adrenergic receptor polymorphisms.
|
BMC Med
|
2007
|
0.91
|
|
15
|
Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.
|
Neurogenetics
|
2010
|
0.90
|
|
16
|
Fine-structural analysis and connexin expression in the retina of a transgenic model of Huntington's disease.
|
J Comp Neurol
|
2004
|
0.90
|
|
17
|
Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study.
|
J Rheumatol
|
2010
|
0.88
|
|
18
|
Spinocerebellar ataxias: an example of the challenges associated with genetic databases for dynamic mutations.
|
Hum Mutat
|
2012
|
0.88
|
|
19
|
NMDA receptor gene variations as modifiers in Huntington disease: a replication study.
|
PLoS Curr
|
2011
|
0.87
|
|
20
|
Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis?
|
Ann Rheum Dis
|
2010
|
0.86
|
|
21
|
Granuloma formation in ANCA-associated vasculitides.
|
APMIS Suppl
|
2009
|
0.86
|
|
22
|
EMQN Best Practice Guidelines for molecular genetic testing of SCAs.
|
Eur J Hum Genet
|
2010
|
0.84
|
|
23
|
PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.
|
Mol Neurodegener
|
2011
|
0.84
|
|
24
|
No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.
|
BMC Med Genet
|
2006
|
0.82
|
|
25
|
Electrophoresis of DNA in human genetic diagnostics - state-of-the-art, alternatives and future prospects.
|
Electrophoresis
|
2006
|
0.80
|
|
26
|
Is the retina affected in Huntington disease?
|
Acta Neuropathol
|
2005
|
0.80
|
|
27
|
Genetic association studies in ANCA-associated vasculitides: what we have learnt so far and what needs to be done in the future.
|
Clin Exp Rheumatol
|
2010
|
0.79
|
|
28
|
Benign SCA14 phenotype in a German patient associated with a missense mutation in exon 3 of the PRKCG gene.
|
Mov Disord
|
2007
|
0.79
|
|
29
|
Polymorphisms in genes encoding leptin, ghrelin and their receptors in German multiple sclerosis patients.
|
Mol Cell Probes
|
2011
|
0.78
|
|
30
|
Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.
|
J Negat Results Biomed
|
2005
|
0.77
|
|
31
|
Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis.
|
PLoS One
|
2013
|
0.77
|
|
32
|
Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study.
|
J Dermatol
|
2010
|
0.76
|
|
33
|
Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.
|
BMC Med Genet
|
2004
|
0.76
|
|
34
|
Growth rate of late passage sarcoma cells is independent of epigenetic events but dependent on the amount of chromosomal aberrations.
|
Exp Cell Res
|
2013
|
0.76
|
|
35
|
Association study with Wegener granulomatosis of the human phospholipase Cgamma2 gene.
|
J Negat Results Biomed
|
2005
|
0.75
|
|
36
|
The future of ANCA-associated vasculitis.
|
Rheum Dis Clin North Am
|
2010
|
0.75
|
|
37
|
Genetic Variation of PPARs.
|
PPAR Res
|
2009
|
0.75
|